1. |
Kitahara CM, Sosa JA. The changing incidence of thyroid cancer. Nat Rev Endocrinol, 2016, 12(11): 646-653.
|
2. |
La Vecchia C, Malvezzi M, Bosetti C, et al. Thyroid cancer mortality and incidence: a global overview. Int J Cancer, 2015, 136(9): 2187-2195.
|
3. |
吕春艳, 廖曼各, 张丽林, 等. 甲状腺乳头状癌颈部淋巴结转移的临床评估进展. 肿瘤学杂志, 2018, 24(4): 297-302.
|
4. |
郭灵敏, 冯伟兆, 李林株, 等. 甲状腺乳头状癌组织中 p-Akt 及 VEGF-C 的表达及临床意义. 中国现代医生, 2020, 58(26): 12-15, 19.
|
5. |
田文, 郗洪庆. 分化型甲状腺癌外科诊疗进展及展望. 中国实用外科杂志, 2020, 40(1): 78-82.
|
6. |
熊雄, 焉正庆, 张爱军. 长链非编码 RNA CBR3-AS1 在乳腺癌中的表达及其功能. 中国普通外科杂志, 2019, 28(11): 1379-1385.
|
7. |
Niu X, Yang B, Liu F, et al. LncRNA HOXA11-AS promotes OSCC progression by sponging miR-98-5p to upregulate YBX2 expression. Biomed Pharmacother, 2020, 121: 109623.
|
8. |
姚林, 谭望, 杨发才, 等. 长链非编码 RNA POU6F2-AS2 在人胃癌组织中的表达及临床意义. 中国普外基础与临床杂志, 2019, 26(5): 563-567.
|
9. |
贺钰斌, 朱丹. 钙化性主动脉瓣疾病发病机制的研究进展. 中国胸心血管外科临床杂志, 2018, 25(2): 171-176.
|
10. |
何璐, 李彦林, 王国梁, 等. 长链非编码 RNA 在骨关节炎软骨损伤中的调控作用. 中国修复重建外科杂志, 2020, 34(11): 1486-1491.
|
11. |
张洋, 郭海, 马莉, 等. 长链非编码 RNA MALAT1 吸附微小 RNA-124 调控 MSCs 成骨分化的实验研究. 中国修复重建外科杂志, 2020, 34(2): 240-245.
|
12. |
张世杰, 张田利, 童翔, 等. 非编码 RNA 在肺纤维化中作用机制的研究进展. 华西医学, 2021, 36(1): 91-96.
|
13. |
侯婉婷, 唐秋琳, 毕锋. 肾透明细胞癌中 lncRNA 和 miRNA 差异表达及相关 ceRNA 调控网络的分析研究. 生物医学工程学杂志, 2019, 36(2): 267-273.
|
14. |
陈舒泽, 于正桐, 王梓鸿, 等. 长链非编码 RNA 中 INK4 基因座中反义非编码 RNA 在糖尿病视网膜病变中的研究现状. 中华眼底病杂志, 2020, 36(1): 78-81.
|
15. |
王凡, 李培, 许芳, 等. 特发性肺间质纤维化中长链非编码 RNA 及转录因子的生物信息学挖掘. 中国呼吸与危重监护杂志, 2020, 19(6): 554-562.
|
16. |
陈凤惟, 张成, 董慧, 等. 慢性间歇低氧上调心肌 lncRNA MALAT1 及相关分子的表达. 中国呼吸与危重监护杂志, 2018, 17(4): 377-382.
|
17. |
龙勃, 展昊, 杜恒锐, 等. 长链非编码 RNA 高表达与胃癌预后不良相关性的 Meta 分析. 中国循证医学杂志, 2018, 18(3): 286-293.
|
18. |
Li J, Lian Y, Yan C, et al. Long non-coding RNA FOXP4-AS1 is an unfavourable prognostic factor and regulates proliferation and apoptosis in colorectal cancer. Cell Prolif, 2017, 50(1): e12312.
|
19. |
Wang D, Bai T, Chen G, et al. Upregulation of long non-coding RNA FOXP4-AS1 and its regulatory network in hepatocellular carcinoma. Onco Targets Ther, 2019, 12: 7025-7038.
|
20. |
Bhaijee F, Nikiforov YE. Molecular analysis of thyroid tumors. Endocr Pathol, 2011, 22(3): 126-133.
|
21. |
杨敏, 王昌敏. 甲状腺乳头状癌差异表达 lnc RNA 的筛选与分析. 新疆医科大学, 2020: 4-5.
|
22. |
Zhang CL, Geng CH, Jian JJ, et al. Correlations of ultrasound and pathological features of thyroid carcinoma with TC-1 mRNA and protein expression. Eur Rev Med Pharmacol Sci, 2019, 23(8): 3440-3446.
|
23. |
金海龙, 张毅, 潘炯. 淋巴结转移率与甲状腺乳头状癌患者术后复发及预后的相关性. 中国综合临床, 2019, 35(1): 14-17.
|
24. |
Lopez-Pajares V. Long non-coding RNA regulation of gene expression during differentiation. Pflugers Arch, 2016, 468(6): 971-981.
|
25. |
Serghiou S, Kyriakopoulou A, Ioannidis JP. Long noncoding RNAs as novel predictors of survival in human cancer: a systematic review and meta-analysis. Mol Cancer, 2016, 15(1): 50-63.
|
26. |
Aune TM, Spurlock CF. Long non-coding RNAs in innate and adaptive immunity. Virus Res, 2016, 212: 146-160.
|
27. |
Yoon JH, Kim J, Gorospe M. Long noncoding RNA turnover. Biochimie, 2015, 117: 15-21.
|
28. |
张冬雪, 刘欣, 陈振文, 等. 长链非编码 RNA GAS8-AS1 在甲状腺微小乳头状癌中的表达特点及临床意义分析. 中华内分泌代谢杂志, 2017, 33(8): 687-692.
|
29. |
Zhang J, Du Y, Zhang X, et al. Downregulation of BANCR promotes aggressiveness in papillary thyroid cancer via the MAPK and PI3K pathways. J Cancer, 2018, 9(7): 1318-1328.
|
30. |
刘玲, 钱潇潇, 宋斌, 等. lncRNA TCONS-00020455 及 TCONS-00020457 在甲状腺乳头状癌中的表达及意义. 南京医科大学学报(自然科学版), 2019, 39(3): 332-337.
|
31. |
Gao H, Sun X, Wang H, et al. Long noncoding RNA SNHG22 increases ZEB1 expression via competitive binding with microRNA-429 to promote the malignant development of papillary thyroid cancer. Cell Cycle, 2020, 19(10): 1186-1199.
|
32. |
Yang L, Ge D, Chen X, et al. FOXP4-AS1 participates in the development and progression of osteosarcoma by downregulating LATS1 via binding to LSD1 and EZH2. Biochem Biophys Res Commun, 2018, 502(4): 493-500.
|
33. |
Chen RY, Ju Q, Feng LM, et al. The carcinogenic complex lncRNA FOXP4-AS1/EZH2/LSD1 accelerates proliferation, migration and invasion of gastric cancer. Eur Rev Med Pharmacol Sci, 2019, 23(19): 8371-8376.
|
34. |
Wu XC, Xiao Y, Zhou Y, et al. LncRNA FOXP4-AS1 is activated by PAX5 and promotes the growth of prostate cancer by sequestering miR-3184-5p to upregulate FOXP4. Cell Death Dis, 2019, 10(7): 472.
|
35. |
Zhao J, Yang T, Li L. LncRNA FOXP4-AS1 is involved in cervical cancer progression via regulating miR-136-5p/CBX4 axis. Onco Targets Ther, 2020, 13: 2347-2355.
|
36. |
宋慧胜, 邱惠思, 吴华振, 等. 特异性蛋白 1 (SP1) 上调 FOXP4-AS1 促进结直肠癌细胞增殖. 中国生物化学与分子生物学报, 2019, 35(3): 304-309.
|
37. |
Li Y, Li T, Yang Y, et al. YY1-induced upregulation of FOXP4-AS1 and FOXP4 promote the proliferation of esophageal squamous cell carcinoma cells. Cell Biol Int, 2020, 44(7): 1447-1457.
|
38. |
Liu XG, Xu H, Chen M, et al. Identify potential clinical significance of long noncoding RNA forkhead box P4 antisense RNA 1 in patients with early stage pancreatic ductal adenocarcinoma. Cancer Med, 2020, 9(6): 2062-2076.
|
39. |
Zhong LK, Zhou J, He X, et al. Long non-coding RNA FOXP4-AS1 acts as an adverse prognostic factor and regulates proliferation and apoptosis in nasopharyngeal carcinoma. Eur Rev Med Pharmacol Sci, 2020, 24(15): 8008-8016.
|